Total Payments
$12,247
2024 Payments
$1,265
Companies
56
Transactions
758
Medicare Patients
4,657
Medicare Billing
$379,509
Payment Breakdown by Category
Food & Beverage$12,222 (99.8%)
Education$24.75 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,222 | 754 | 99.8% |
| Education | $24.75 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,992 | 129 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,624 | 85 | $0 (2024) |
| Allergan, Inc. | $1,590 | 129 | $0 (2022) |
| Lilly USA, LLC | $861.16 | 70 | $0 (2024) |
| GlaxoSmithKline, LLC. | $590.40 | 33 | $0 (2024) |
| Novo Nordisk Inc | $506.59 | 40 | $0 (2024) |
| Galderma Laboratories, L.P. | $485.72 | 14 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $410.10 | 31 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $322.95 | 22 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $260.99 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,265 | 64 | ABBVIE INC. ($390.39) |
| 2023 | $1,569 | 87 | ABBVIE INC. ($469.40) |
| 2022 | $1,119 | 67 | ABBVIE INC. ($345.30) |
| 2021 | $2,200 | 108 | AbbVie Inc. ($563.18) |
| 2020 | $1,392 | 86 | Allergan, Inc. ($420.86) |
| 2019 | $1,701 | 113 | Allergan Inc. ($463.37) |
| 2018 | $1,491 | 121 | Allergan Inc. ($374.91) |
| 2017 | $1,509 | 112 | Takeda Pharmaceuticals America, Inc. ($223.41) |
All Payment Transactions
758 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Hyperthyroidism | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Obesity | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: VACCINES | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Obesity | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,312 | 1,815 | $262,451 | $117,976 |
| 2022 | 14 | 1,371 | 1,710 | $237,715 | $108,271 |
| 2021 | 12 | 1,076 | 1,325 | $184,222 | $86,659 |
| 2020 | 9 | 898 | 1,185 | $177,338 | $66,603 |
Total Patients
4,657
Total Services
6,035
Medicare Billing
$379,509
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 804 | $173,664 | $69,627 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 215 | 215 | $49,880 | $26,817 | 53.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 229 | 229 | $11,908 | $5,734 | 48.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 34 | 34 | $4,760 | $4,447 | 93.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 213 | 213 | $5,751 | $3,787 | 65.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 144 | 144 | $5,184 | $2,560 | 49.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,649 | $1,289 | 78.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,536 | $1,186 | 26.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $1,020 | $999.60 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $600.00 | $588.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 44 | $1,496 | $477.73 | 31.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 13 | $1,598 | $403.70 | 25.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 27 | $405.00 | $59.40 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 631 | $136,296 | $52,378 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 206 | 206 | $47,792 | $26,213 | 54.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 226 | 226 | $11,752 | $5,793 | 49.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 42 | 42 | $5,880 | $5,543 | 94.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 226 | 226 | $8,136 | $4,098 | 50.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 204 | 204 | $5,508 | $3,632 | 65.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 21 | 21 | $6,972 | $3,426 | 49.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 26 | 26 | $2,522 | $1,797 | 71.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 42 | 42 | $1,260 | $1,208 | 95.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,597 | $1,174 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,050 | $1,003 | 95.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,592 | $783.65 | 30.2% |
About Dr. Arneyo Perez, MD
Dr. Arneyo Perez, MD is a Family Medicine healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780662619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arneyo Perez, MD has received a total of $12,247 in payments from pharmaceutical and medical device companies, with $1,265 received in 2024. These payments were reported across 758 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($12,222).
As a Medicare-enrolled provider, Perez has provided services to 4,657 Medicare beneficiaries, totaling 6,035 services with total Medicare billing of $379,509. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Scottsdale, AZ
- Active Since 12/30/2005
- Last Updated 12/07/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780662619
Products in Payments
- FARXIGA (Drug) $1,294
- VRAYLAR (Drug) $734.05
- UBRELVY (Drug) $723.88
- SHINGRIX (Biological) $481.64
- Trintellix (Drug) $393.61
- ZENPEP (Drug) $347.95
- LINZESS (Drug) $324.72
- QULIPTA (Drug) $319.81
- VIBERZI (Drug) $319.66
- TRULICITY (Drug) $315.50
- BYSTOLIC (Drug) $267.95
- JARDIANCE (Drug) $259.27
- Dayvigo (Drug) $251.43
- XIFAXAN (Drug) $249.57
- BOTOX (Biological) $189.44
- Ozempic (Drug) $186.03
- BREZTRI (Drug) $170.40
- MOUNJARO (Drug) $169.10
- NURTEC ODT (Drug) $165.46
- JANUVIA (Drug) $162.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Scottsdale
Dr. Sam Fereidouni, M.d, M.D
Family Medicine — Payments: $728,768
Family Medicine $728,768
Joseph Lillo, Do, Fnla, Fapcr, DO, FNLA, FAPCR
Family Medicine — Payments: $139,851
Family Medicine $139,851
Dr. Martin Blume, D.o. Mba, D.O. MBA
Family Medicine — Payments: $82,430
Family Medicine $82,430
Dr. Renee Davis, Do, Mph, DO, MPH
Family Medicine — Payments: $42,875
Family Medicine $42,875
James Steiner, Md, MD
Family Medicine — Payments: $15,385
Family Medicine $15,385
Mrs. Christine Ragay-Cathers, D.o, D.O
Family Medicine — Payments: $10,175
Family Medicine $10,175